Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-stage biopharmaceutical company focused on cellular energy restoration therapeutics, today announced it will present clinical application ...

IntroductionThe global healthcare IT market is witnessing a significant transformation, driven by rapid technological advancements and a growing emphasis on digital healthcare ecosystems, and is ...

Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-stage biopharmaceutical company focused on cellular energy restoration therapeutics, today announced ...

An NSO survey on household consumption shows marked improvement in healthcare access, affordability, and utilization across India, driven by expanded public health infrastructure, higher insurance ...

InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today ...

At WIRED Health, British surgeon Ara Darzi said AI is set to transform the diagnosis and treatment of drug-resistant infections. But a lack of incentives means innovation may not reach patients.

AI could "give the scientific community a way to address the most difficult and urgent questions in human health," argues ...

The global Hemostats Market is projected to reach a value of $2.7 billion by 2025 and is expected to experience a robust ...

Today, Biohub announced the Virtual Biology Initiative, a landmark five-year initiative to galvanize a global effort to create the technologies and multi-modal datasets needed to build predictive ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has met or exceeded all statutory performance targets, ...